Influenzinum 200C
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
44911-0664 -
Package NDC
44911-0664-1 -
SPL ID
ccb581f5-9fff-4d28-9c1a-e21700646fbe -
SPL set ID
80fb9604-cfc4-40fc-bc06-a68e7c1781cb -
UNII
34C49NV47P -
UNII
P483J7GX6D -
UNII
TBV2PPG6EF -
UNII
H2198F8ZNA
What the source publishes
- Labeler
- Energique, Inc.
- Active ingredients
- Influenzinum (2022-2023)
- Form
- LIQUID
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- UNAPPROVED HOMEOPATHIC
- Product type
- HUMAN OTC DRUG
- Prescription
- Non-prescription
Names this record is found by
- Influenzinum 200C
- Influenzinum (2022-2023)
- INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
- INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
- INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
Complete source data
{
"name": "Influenzinum 200C",
"splId": "ccb581f5-9fff-4d28-9c1a-e21700646fbe",
"labels": [
{
"setId": "80fb9604-cfc4-40fc-bc06-a68e7c1781cb",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80fb9604-cfc4-40fc-bc06-a68e7c1781cb",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=80fb9604-cfc4-40fc-bc06-a68e7c1781cb"
}
],
"routes": [
"ORAL"
],
"labeler": "Energique, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 mL in 1 BOTTLE, DROPPER (44911-0664-1)",
"package_ndc": "44911-0664-1",
"identifierStatus": "well-formed",
"marketing_end_date": "20271228",
"marketing_start_date": "20221229"
}
],
"productId": "44911-0664_ccb581f5-9fff-4d28-9c1a-e21700646fbe",
"useDomain": "unknown",
"dosageForm": "LIQUID",
"productNdc": "44911-0664",
"deaSchedule": null,
"genericName": "Influenzinum (2022-2023)",
"productType": "HUMAN OTC DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": "20271228",
"activeIngredients": [
{
"name": "INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)",
"strength": "200 [hp_C]/mL"
},
{
"name": "INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)",
"strength": "200 [hp_C]/mL"
},
{
"name": "INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)",
"strength": "200 [hp_C]/mL"
},
{
"name": "INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)",
"strength": "200 [hp_C]/mL"
}
],
"applicationNumber": null,
"marketingCategory": "UNAPPROVED HOMEOPATHIC",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20221229",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "non-prescription",
"harmonizedIdentifiers": {
"upc": [
"0363113600056"
],
"unii": [
"34C49NV47P",
"P483J7GX6D",
"TBV2PPG6EF",
"H2198F8ZNA"
],
"spl_set_id": [
"80fb9604-cfc4-40fc-bc06-a68e7c1781cb"
],
"manufacturer_name": [
"Energique, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:44911-0664_ccb581f5-9fff-4d28-9c1a-e21700646fbe"